Rotterdam, Netherlands

Arnold J Reuser

This inventor holds 1 USPTO granted patent. Top assignees: Academic Hospital, Eramus Universiteit, Leiden University. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 85(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arnold J Reuser: Innovator in Transgenic Technology

Introduction

Arnold J Reuser is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic animals for pharmaceutical applications. His work focuses on the production of lysosomal proteins, which are crucial for various medical therapies.

Latest Patents

Arnold J Reuser holds a patent for "Lysosomal proteins produced in the milk of transgenic animals." This invention provides transgenic nonhuman mammals that produce phosphorylated lysosomal proteins in their milk. The phosphorylation occurs at the 6' position of a mannose side chain residue. Additionally, the patent outlines methods for purifying lysosomal proteins from milk and incorporating these proteins into pharmaceutical compositions for use in enzyme replacement therapy. He has 1 patent to his name.

Career Highlights

Throughout his career, Arnold J Reuser has worked with prominent organizations, including Pharming B.V. and Universiteit Leiden. His expertise in transgenic technology has positioned him as a key figure in the biotechnology sector. His innovative approaches have paved the way for advancements in enzyme replacement therapies.

Collaborations

Arnold has collaborated with esteemed colleagues such as Ans T Van Der Ploeg and Frank R Pieper. These partnerships have further enhanced his research and development efforts in the field of biotechnology.

Conclusion

Arnold J Reuser's contributions to the field of transgenic technology and lysosomal protein production have had a lasting impact on biotechnology and pharmaceutical development. His innovative work continues to influence the future of enzyme replacement therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…